{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:07:35Z","timestamp":1761170855199,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T00:00:00Z","timestamp":1638662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Egyptian Rheumatologist"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ejr.2021.12.002","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T21:47:39Z","timestamp":1639086459000},"page":"209-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Frequency, characteristics and outcome of corona virus disease 2019 (COVID-19) infection in Iranian patients with rheumatic diseases"],"prefix":"10.1016","volume":"44","author":[{"given":"Shirin","family":"Assar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dena","family":"Mohamadzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehran","family":"Pournazari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parviz","family":"Soufivand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejr.2021.12.002_b0005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/rheumatology\/kes305","article-title":"The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment","volume":"52","author":"Listing","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ejr.2021.12.002_b0010","doi-asserted-by":"crossref","first-page":"e000935","DOI":"10.1136\/rmdopen-2019-000935","article-title":"Serious infection risk in rheumatoid arthritis compared with non-inflammatory rheumatic and musculoskeletal diseases: a US national cohort study","volume":"5","author":"Mehta","year":"2019","journal-title":"RMD Open"},{"issue":"8","key":"10.1016\/j.ejr.2021.12.002_b0015","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/acr.22575","article-title":"Burden of serious infections in adults with systemic lupus erythematosus: a national population-based study, 1996\u20132011","volume":"67","author":"Tektonidou","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"10.1016\/j.ejr.2021.12.002_b0020","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/art.39596","article-title":"Incidence of severe infections and infection-related mortality during the course of giant cell arteritis: a multicenter, prospective, double-cohort study","volume":"68","author":"Schmidt","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.ejr.2021.12.002_b0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejr.2021.08.013","article-title":"Systemic lupus erythematosus after coronavirus disease-2019 (COVID-19) infection: Case-based review","volume":"44","author":"Assar","year":"2022","journal-title":"Egypt Rheumatol"},{"issue":"1","key":"10.1016\/j.ejr.2021.12.002_b0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejr.2020.07.001","article-title":"Impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection and disease-2019 (COVID-19) on the quality of life of rheumatoid arthritis patients in Benin","volume":"43","author":"Zomalheto","year":"2021","journal-title":"Egypt Rheumatol"},{"issue":"2","key":"10.1016\/j.ejr.2021.12.002_b0035","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00296-020-04736-9","article-title":"ECR COVID19-Study Group. Impact of COVID-19 pandemic on rheumatoid arthritis from a Multi-Centre patient-reported questionnaire survey: influence of gender, rural-urban gap and north-south gradient","volume":"41","author":"Abualfadl","year":"2021","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.ejr.2021.12.002_b0040","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ejr.2021.05.001","article-title":"Six month assessment of low dose rituximab in the treatment of rheumatoid arthritis during coronavirus disease 2019 (COVID-19) pandemic","volume":"43","author":"Durmaz","year":"2021","journal-title":"Egypt Rheumatol"},{"issue":"6","key":"10.1016\/j.ejr.2021.12.002_b0045","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/annrheumdis-2020-217322","article-title":"Are my patients with rheumatic diseases at higher risk of COVID-19?","volume":"79","author":"Figueroa-Parra","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ejr.2021.12.002_b0050","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/annrheumdis-2020-217460","article-title":"Role of immunosuppressive therapy in rheumatic diseases concurrent with COVID-19","volume":"79","author":"Lu","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"10229","key":"10.1016\/j.ejr.2021.12.002_b0055","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ejr.2021.12.002_b0060","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00296-021-04941-0","article-title":"Egyptian College of Rheumatology (ECR) COVID-19 Study Group. Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt","volume":"41","author":"Hammam","year":"2021","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.ejr.2021.12.002_b0065","doi-asserted-by":"crossref","first-page":"e001814","DOI":"10.1136\/rmdopen-2021-001814","article-title":"Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey","volume":"7","author":"Sattui","year":"2021","journal-title":"RMD Open"},{"issue":"8","key":"10.1016\/j.ejr.2021.12.002_b0070","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.ejr.2021.12.002_b0075","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ejr.2021.12.002_b0080","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3899\/jrheum.110845","article-title":"The ClASsification for psoriatic ARthritis (CASPAR) criteria \u2013 a retrospective feasibility, sensitivity, and specificity study: table 1","volume":"39","author":"Tillett","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejr.2021.12.002_b0085","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.ejr.2021.12.002_b0090","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"Classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"Khanna","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejr.2021.12.002_b0095","first-page":"9","article-title":"American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sjogren\u2019s syndrome","volume":"2017","author":"Shiboski","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejr.2021.12.002_b0100","unstructured":"International Team for the Revision of the International Criteria for Behcet's Disease (ITR-ICBD). Revision of the International Criteria for Behcet's disease (ICBD). Clin Exp Rheumatol. 2006;24(Suppl 42):S14-5."},{"key":"10.1016\/j.ejr.2021.12.002_b0105","doi-asserted-by":"crossref","unstructured":"Bohan A, Peter JB. Polymyositis and Dermatomyositis. N Engl J Med 1975February13;292(7):344\u20137.","DOI":"10.1056\/NEJM197502132920706"},{"issue":"4","key":"10.1016\/j.ejr.2021.12.002_b0110","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1473-3099(20)30858-6","article-title":"SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study","volume":"21","author":"Poustchi","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.ejr.2021.12.002_b0115","doi-asserted-by":"crossref","first-page":"455","DOI":"10.34172\/aim.2020.42","article-title":"Global Incidence and Mortality Rate of COVID-19; Special Focus on Iran, Italy and China","volume":"23","author":"Chaibakhsh","year":"2020","journal-title":"Arch Iran Med"},{"issue":"6","key":"10.1016\/j.ejr.2021.12.002_b0120","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/jmv.25722","article-title":"Understanding of COVID-19 based on current evidence","volume":"92","author":"Sun","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.ejr.2021.12.002_b0125","doi-asserted-by":"crossref","unstructured":"Favalli EG, Ingegnoli F, Cimaz R, Caporali R. What is the true incidence of COVID-19 in patients with rheumatic diseases?. Ann Rheum Dis 2021;80:e18.","DOI":"10.1136\/annrheumdis-2020-217615"},{"issue":"9","key":"10.1016\/j.ejr.2021.12.002_b0130","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/annrheumdis-2020-217888","article-title":"Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'","volume":"79","author":"D\u2019Silva","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.ejr.2021.12.002_b0135","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1007\/s10067-020-05334-7","article-title":"COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series","volume":"39","author":"Ferri","year":"2020","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.ejr.2021.12.002_b0140","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1136\/annrheumdis-2020-217763","article-title":"Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases","volume":"79","author":"Pablos","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ejr.2021.12.002_b0145","doi-asserted-by":"crossref","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.ejr.2021.12.002_b0150","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.semarthrit.2020.05.001","article-title":"Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs","volume":"50","author":"Michelena","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.ejr.2021.12.002_b0155","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","article-title":"Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry","volume":"79","author":"Gianfrancesco","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejr.2021.12.002_b0160","doi-asserted-by":"crossref","first-page":"104378","DOI":"10.1016\/j.jcv.2020.104378","article-title":"Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study","volume":"127","author":"Nikpouraghdam","year":"2020","journal-title":"J Clin Virol"},{"issue":"6","key":"10.1016\/j.ejr.2021.12.002_b0165","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1136\/annrheumdis-2020-217480","article-title":"Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist","volume":"79","author":"Graef","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ejr.2021.12.002_b0170","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/annrheumdis-2020-217566","article-title":"Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine","volume":"79","author":"Mathian","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.ejr.2021.12.002_b0175","doi-asserted-by":"crossref","first-page":"e689","DOI":"10.1016\/S2665-9913(20)30305-2","article-title":"Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study","volume":"2","author":"Gentry","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.ejr.2021.12.002_b0180","first-page":"keaa897","article-title":"Incidence and severeness of COVID-19 hospitalisation in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark","author":"Cordtz","year":"2020","journal-title":"Rheumatology (Oxford)"}],"container-title":["The Egyptian Rheumatologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1110116421001058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1110116421001058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:17:30Z","timestamp":1761103050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1110116421001058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1110116421001058"],"URL":"https:\/\/doi.org\/10.1016\/j.ejr.2021.12.002","relation":{},"ISSN":["1110-1164"],"issn-type":[{"type":"print","value":"1110-1164"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frequency, characteristics and outcome of corona virus disease 2019 (COVID-19) infection in Iranian patients with rheumatic diseases","name":"articletitle","label":"Article Title"},{"value":"The Egyptian Rheumatologist","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejr.2021.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Egyptian Society of Rheumatic Diseases. Publishing services provided by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}